| 摘要 |
<p>A stable drug composition of (R)-2-(4-bromo-2-fluorobenzyl)-1,2,3,4-tetrahydropyrrolo[1,2-a]pyrazine-4-spiro-3'-pyrrolidine-1,2',3,5'-tetraone (referred to as AS-3201), which contains a stabilizer comprising at least one acidic substance having an acidity higher than that of AS-3201, such as ascorbic acid, citric acid, tartaric acid, lactic acid, maleic acid, malic acid or phosphoric acid.</p> |
